Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Vigil Neuroscience Inc VIGL

Healthcare Biotechnology
Vigil Neuroscience, Inc. is a clinical-stage biotechnology company, which is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based... see more

Current News (NDAQ:VIGL)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:VIGL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VIGL)

Still holding this stock.BUY

Because it's being bought out today for a big amount ofcash and shares
coolfooldumbguy - May 22, 2025

Vigil Neuroscience (NASDAQ:VIGL): A Precision Approach to Ne

Looks like a promising play in the neuro space. VIGL's TREM2 agonist approach for rare neurodeg diseases is intriguing. Phase 2...
MikeTester - January 23, 2025

Buy buddy buy because it's taking off this morning.

So good luck to all of you shareholders.
coolfooldumbguy - January 23, 2025

Vigil Neuroscience, Inc. (VIGL): A Promising Biotech Poised

http://beyondspx.com/2024/08/03/vigil-neuroscience-inc-vigl-a-promising-biotech-poised-to-revolutionize-neurodegenerative-disease...
MikeTester - August 3, 2024

Going to $5+ easily

Next week. 
Garanga - July 5, 2024
View more Bullboard ››

Nightfood Holdings, Inc.

Nightfood Holdings, Inc.

Nightfood Holdings, Inc., through its subsidiaries, operates as a hospitality technology company. It operates through ...
View More »

Podcasts